Boeing

Boeing is one of two companies on Earth that can build a large commercial airliner. That is not a figure of speech: between Boeing and Airbus, the pair have essentially the entire market for jets carrying more than 130 people, protected by barriers that are close to insurmountable — a decade and ten billion dollars to develop a new aircraft, certification regimes measured in years, airline fleets locked in by pilot type ratings and maintenance infrastructure, and order books stretching two decades out. It is one of the widest moats in industry.

And Boeing spent twenty years damaging it from the inside.

The numbers say it plainly. In 2018, Boeing earned $10.46 billion on revenue of $101.1 billion, with its commercial aircraft division running a 13.0% operating margin. In the seven years since it has lost money in six of them, burned $33.7 billion of cash, watched shareholders' equity go negative for five consecutive years, suspended its dividend, and been criminally charged over the deaths of 346 people. Its commercial division's operating margin went from +13.0% to −17.1%. Nothing external did this. Airbus did not take the market; no technology made the 737 obsolete; demand never fell. The backlog today is $715 billion and 6,202 aircraft — larger than at the absolute peak. The customers never left. Boeing simply lost the ability to build what they had already bought.

"There will be no more moonshots." — Jim McNerney, CEO, 21 May 2014. Nine weeks later, asked if he would retire at 65: "The heart will still be beating, the employees will still be cowering."

Those two sentences, nine weeks apart in McNerney's last full year as chief executive, are the whole story compressed. One renounced the engineering ambition that had built the company — the "moonshots" being the 707 and the 747, the bet-the-company aircraft. The other described how the engineers were expected to feel about it. The analyst Richard Aboulafia read the first remark at the time as "further implying that Boeing was no longer an engineering company." He was right, and the bill arrived in the Java Sea four years later.

What makes Boeing worth analysing now — rather than simply condemning — is that the repair is finally, measurably real. In the twelve days before we published this, two of the three great overhangs lifted: the criminal case was closed by the Fifth Circuit, and the FAA restored Boeing's authority to certify its own aircraft. Production is running at 47 jets a month against a frozen 38. The company delivered 171 aircraft last quarter, its best since 2018. The question for an investor is no longer whether Boeing survives. It is what you should pay for a wreck that is genuinely being fixed — and whether the fixing is already in the price.

The 2011 decision is the one that matters, and it is the reason this report belongs on a value-investing site rather than in a news archive. Faced with a competitive threat, Boeing chose the cheap, fast, low-capital answer over the expensive, slow, correct one — and then spent on its own shares three to four times what the correct answer would have cost. Boeing could have bought the future outright. It bought the stock instead — and then, six years later, had to buy the stock's replacement back from the public at a sixty percent discount.

Be careful here, because Boeing invites a specific error. The proposition is so easy to state — half a duopoly, record backlog, must eventually recover — that investors skip the accounts. But Boeing uses program accounting, which spreads the cost of an aircraft programme across a projected run of hundreds of units, and when the estimate of that run's total cost deteriorates, the entire cumulative shortfall lands at once as a "reach-forward loss." The result is an income statement in which 2025 shows a net profit of $2.23 billion sitting on top of an operating LOSS of $5.42 billion — the bottom line rescued by non-operating items while the actual business of building aeroplanes still lost money. Anyone reading the net-income line alone would conclude Boeing had returned to profit. It has not.

Read those three lines together and the company becomes legible. BGS is a genuinely excellent business — high-margin, recurring, tied to an installed base that cannot be displaced — and it was profitable every single year of the disaster. BDS was the chronic wound and is now close to breakeven. And BCA is where all the value and all the damage sit: a franchise with a record order book that has been losing money on almost every jet it delivers. The bull case for Boeing is not complicated. It is the single arithmetic fact that BCA's margin was +13.0% at the peak and −17.1% last year, on a backlog that is now bigger than it was at the peak. If that line simply returns to half its former margin, the earnings power of this company is transformed. If it does not, the equity is a call option on a company with $54 billion of debt.

Here is the finding that surprised us most, and it should reframe how you think about this company: Boeing's moat survived the worst corporate safety crisis in modern aviation almost entirely intact.

The backlog grew through the catastrophe. At the 2018 peak, Boeing's backlog was $490 billion and ~5,900 aircraft. Today — after two fatal crashes, a 20-month grounding, a door plug departing an aircraft in flight, a criminal charge and years of delivery failures — the backlog is $715 billion and 6,202 aircraft, an all-time record, with all three segments at records. That is the moat speaking, and what it says is simple: airlines cannot switch. Fleet commonality, pilot type ratings, maintenance infrastructure, spares pools and financing structures are twenty-year commitments. And critically, Airbus is sold out into the 2030s — so the alternative to a bad Boeing delivery slot is not an Airbus slot. It is no slot at all.

What protects it: a genuine duopoly (Airbus's backlog is 9,222 aircraft — larger, but the two of them are the entire market); certification barriers measured in years; $10–15 billion and a decade to develop a competing aircraft; and switching costs that lock an airline in for a generation. The Chinese challenger has not arrived: COMAC's C919 received its certificate in 2022 and has delivered roughly 35 aircraft cumulatively — three in the first quarter of 2026 — against a backlog that is essentially all Chinese state carriers, with no firm Western orders. It is a real long-term threat and a negligible near-term one.

What was damaged is not the demand — it is the trust and the execution. The FAA froze production expansion for nearly two years; Boeing lost the authority to certify its own aircraft; and every rate increase now requires a regulator's blessing. That is a moat with a government-appointed gatekeeper standing in the middle of it. I score the moat an 8 — as wide a demand moat as exists in industry, marked down two points not for competitive erosion but because the company demonstrated it could not reliably convert the moat into aircraft, and because a regulator now governs the pace at which it may try.

We came to this analysis expecting to write a post-mortem. The evidence does not support one. In the two weeks before publication, the two largest overhangs on this company lifted, and the operating numbers have genuinely inflected. An honest analysis has to say so.

Our read: the repair is genuine, and it is roughly two-thirds done. Ortberg has fixed what could be fixed by management — he brought Spirit AeroSystems back in-house (closing December 2025 for $8.4 billion of total consideration) to regain nose-to-tail control of fuselage quality; he has rebuilt the relationship with the FAA to the point of full ODA restoration; he has stopped the defence bleeding; and he has the factory running at its highest authorised rate in three years. Those are not narrative claims — they are dated, verifiable events, and most of them happened in the last nine months.

What has not been fixed is the thing that takes longest: converting a record backlog into cash at an acceptable margin. BCA still lost $885 million in the first half of 2026. Free cash flow guidance for the whole year is $1–3 billion, against $13.6 billion generated in 2018. And two structural tells suggest the quality problem is not fully behind them: warranty provisions rose to $3.27 billion with $521 million of upward re-estimates in the first half of 2026, against $298 million in the same period of 2025 — the rate of adverse revision is accelerating, which is what a company looks like when field problems are still emerging. So: a real recovery, materially de-risked, still a long way from earning its cost of capital — and, as Part IX shows, already priced as though the recovery is largely complete.

We have written twenty-eight of these reports and criticised capital allocation in many of them. Nothing we have found compares to this.

Boeing spent forty-three billion dollars retiring a quarter of its shares, and today has more shares outstanding than when it began. In October 2024 it sold 129,375,000 shares at $143.00, plus $5.75 billion of convertibles — $24.25 billion gross, the largest follow-on equity offering in history — for one reason: to stop the credit rating falling into junk. It repurchased high and issued low, the precise inverse of what a buyback is for.

And note the nuance, because it is more damning than the simple version. The repurchases were not disastrously mistimed in isolation — the average cost of $168.40 is below today's $218, so on paper those shares are worth more than was paid. The catastrophe is the opportunity cost. Over a dollar-weighted average holding period of about ten years, the compound return on Boeing's single largest capital allocation decision is roughly 2.6% a year — far below its cost of capital and far below simply owning the index. Meanwhile the $43.4 billion was three to four times the estimated cost of developing the clean-sheet 737 successor that Boeing decided in 2011 it could not afford. It had the money. It gave the money to shareholders, who then had to give it back at a sixty percent discount.

One detail deserves to be read twice: on 17 December 2018 — seven weeks after Lion Air 610 — Boeing's board authorised a new $20 billion repurchase programme. Three months later the global fleet was grounded and essentially none of it was ever spent.

How do you score management here? The honest answer is that you are scoring two different companies. The record of 2005–2020 is, in our view, the worst capital-allocation and cultural record of any business we have analysed. The record since August 2024 is genuinely good — decisive, engineering-led, and validated by regulators and the numbers. I score it a 4: the mark is for the institution, not the incumbent, because the buyback disaster and the negative equity that followed are still sitting in the accounts today and will constrain this company for years. But the direction of travel under Ortberg is the single strongest reason to take the recovery seriously. The Buffett caution applies exactly here, though: if the case rests on one man, that is not a moat — it is a bet on a surgeon.

Two things in this table deserve emphasis. The first is the equity line. From 2020 to 2024, Boeing's shareholders' equity was negative — −$18.3 billion, −$15.0 billion, −$15.9 billion, −$17.2 billion, −$3.9 billion — meaning the company's liabilities exceeded its assets for five consecutive years. It returned to positive territory in 2025 at just $5.45 billion, and it did so not because it earned its way back but because it sold $24 billion of stock. Against $54.4 billion of debt, that is a debt-to-equity ratio of ten. There is no cushion here. This is why the credit rating — BBB−/Baa3, one notch above junk throughout — was the thing Ortberg spent $24 billion to defend, and why we score financial strength a 3.

The second is that almost every conventional valuation ratio for Boeing is meaningless. The price-to-earnings ratio reads 81×, but on earnings that are positive only because of non-operating items. Price-to-book reads 28×, but only because book value was nearly wiped out. Price-to-free-cash-flow reads 702×. The Altman-Z score of 1.55 sits in distress territory. None of these are useful; all of them will be quoted by screens. The only honest way to value this company is against normalised, mid-cycle earnings power — which is what Part IX does.

Since the ordinary yardsticks are unusable, we have to value Boeing the way you would value any cyclical wreck: against what it can earn when it is fixed, and against the value of what it already holds.

Start with the strongest bull argument, because it is a real one: at an enterprise value of roughly $211 billion against a contracted backlog of $715 billion, you are paying about 28 cents for every dollar of future revenue Boeing has already sold. That backlog represents roughly eight years of production at current rates, from customers who cannot go anywhere else. If you believe Boeing eventually converts that at anything like a normal margin, today's price is not demanding. Push it further: if Boeing ever returns to its 2018 earnings of $17.85 a share, you are paying about 12 times peak earnings — and the analysts, at a mean target of $277 (+26.9%) with 36 buys against 5 sells, broadly take that view.

Now the discipline, and it is unavoidable. Consensus expects Boeing to lose money again in 2026. The first profitable year is 2027, at $4.04 a share — which is 54 times today's price. Even in 2028, on $8.01 of earnings, you are paying 27 times. The 2030 estimate that makes the stock look reasonable at ~15× rests on the models of five analysts, forecasting five years out, for a company that has missed almost every schedule it has published for a decade — the 777X alone has slipped repeatedly and now targets first delivery in 2027. This is precisely the pattern we flagged at Eli Lilly, but with far worse execution history behind it.

And there is no margin of safety in the balance sheet to fall back on. A company with $54 billion of debt against $5.45 billion of equity, a distress-range Altman-Z of 1.55, no dividend, and free cash flow guided to $1–3 billion has no cushion if the ramp stalls or another quality escape occurs. The equity is, quite literally, the residual claim after a very large pile of debt — which is why it moves so violently on operational news.

So the verdict is "The Repair Is Real — The Price Assumes It Works." I score valuation a 4. This is not a short call and not a condemnation: Boeing at $218 is a legitimate recovery holding for an investor who understands they are buying a leveraged option on execution, and the backlog-based case genuinely supports the price if the margin recovers. But there is no discount for the risk that it does not. Our buy zone is $180 — near the 52-week low of $176.77, a level this stock traded at within the past year, roughly 22× the 2028 estimate and ~10× peak earnings — where you would finally be paid something for taking on a rate ramp, a fourth production line that still needs certifying, and a decade-long record of missed schedules.